Find a TenderAwarded without competitionTransparency notice
Published 21 Oct 2025, 15:30 BST

Official UK procurement notice

Respiratory Metagenomics Expansion Programme

Official notice

Authority: Guy's and St Thomas' NHS Foundation Trust (Central government)

Direct award
Awarded value£7,010,966published award · exc. VAT
Award in standstill Not publishedno call for competition
Award (standstill) to Oxford Nanopore Technologies

What is being bought

Published requirement description

The contracting authority, Guys and St Thomas's NHS Foundation Trust (GSTT), intends to award a contract for the delivery of Respiratory Metagenomic Clinical Services to Oxford Nanopore Technologies PLC after being granted funding from NHS England (NHSE) and the Department of Science, Innovation and Technology for the financial years 2025/26 to be the lead provider of the programme supporting 9 NHS Trusts with the option to expand to other participants

The lotProcurement structure

single lot · no lot value published

Procedure terms & legal framework

From the official record
Procedure method
Direct award
Legal basis
UKPGA · 2023/54 Procurement Act 2023
Notice status
Awarded without competition
Procurement threshold
Unspecified in notice
Regulatory regime
Standard
Commercial structure
Stand-alone contract (no framework)
Competition type
Direct award (no call for competition)
GPA / WTO covered
Unspecified in notice
Recurring procurement
Unspecified in notice
First published
21 Oct 2025, 15:30 BST
Last source update
21 Oct 2025, 15:30 BST
Authority reference
C395947
FTS notice number
2025/S 000-067168
Latest notice
Transparency notice (UK5)
Delivery area
North East (UKC)North West (UKD)Yorkshire & Humber (UKE)East Midlands (UKF)West Midlands (UKG)East of England (UKH)London (UKI)South East (UKJ)
+1 moreSouth West (UKK)
Official registry OCID
ocds-h6vhtk-05d0df Find a Tender
Why no open competition
Single Suppliers Intellectual Property Exclusive Rights
Published justification

In accordance with Section 41 and Schedule 5 of the PA23, this direct award is to be made on the grounds of absence of competition for technical reasons as the products and services are subject to patented technology by Oxford Nanpore Technologies PLC. It is unique in that it is the only sequencing technology available on the market that enables direct, real-time analysis of short to ultra-long fragments of DNA/RNA, in fully scalable formats. No other provider is able to supply equivalent goods or services.

  • Additional Information - The contracting authority has concluded that the conditions for a direct award are satisfied due to their being no alternatives and an absence of competition due to patent status of the required products and services. A Contract Award Notice (UK6) will be published following the expiry of the standstill period.

Notice history

2 events · 1 release on Find a Tender · since 21 Oct 2025
  1. Transparency notice published
    21 Oct 2025, 15:30 BST
    UK5
  2. Contract signature expected
    31 Oct 2025, 23:59 GMT
    scheduled

Commercial outcome & contract awards

Published awards, contracts and bid statistics, not a forecast
Awards 1some still in standstill
Awarded value £7,010,9661 award exc. VAT
Awarded toValueDateStatus
Oxford Nanopore Technologies1 Nov 2025 – 31 Oct 2028£7,010,966—Standstill

Contracting authority & participating public bodies

GUY'S AND ST THOMAS' NHS FOUNDATION TRUST

Contracting authorityPublic authority - central government GB-NHS: RJ1 · GB-PPON: PDZC-6438-DGPX Great Maze Pond, London, London, SE1 9RTContact email

Bidders & participating suppliers

1 commercial party on the notice
  • OXFORD NANOPORE TECHNOLOGIES PLCAwarded supplierGB-COH: 05386273GB-PPON: PNQY-3648-RQHN Gosling Building Edmund Halley Road, Oxford, South East, OX4 4DQContact email

Official documents & specifications (1)

Official links; attachments are not copied

Notices published for this procedure

  • Transparency notice awardTransparency noticeUK5Transparency notice on Find a Tender